4'-O-methylbavachalcone improves vascular cognitive impairment by inhibiting neuroinflammation via EPO/Nrf2/HO-1 pathway.
10.19540/j.cnki.cjcmm.20250311.701
- Author:
Xin-Yuan ZHANG
1
;
Chen WANG
2
;
Hong-Qing CHEN
1
;
Xiang-Bing ZENG
1
;
Jun-Jie WANG
1
;
Qing-Guang ZHANG
2
;
Jin-Wen XU
2
;
Shuang LING
1
Author Information
1. School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine Shanghai 201203, China.
2. Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine Shanghai 201203, China.
- Publication Type:Journal Article
- Keywords:
4′-O-methylbavachalcone;
NLRP3/AIM2/caspase-1/GSDMD;
Nrf2/HO-1;
neuroinflammation;
vascular cognitive impairment;
white-matter lesions
- MeSH:
Animals;
Male;
Rats, Sprague-Dawley;
NF-E2-Related Factor 2/immunology*;
Rats;
Chalcones/administration & dosage*;
Cognitive Dysfunction/metabolism*;
Signal Transduction/drug effects*;
Neuroinflammatory Diseases/drug therapy*;
Heme Oxygenase-1/metabolism*;
Humans;
Heme Oxygenase (Decyclizing)/genetics*
- From:
China Journal of Chinese Materia Medica
2025;50(14):3990-4002
- CountryChina
- Language:Chinese
-
Abstract:
This study aims to explore the effects and mechanisms of 4'-O-methylbavachalcone(MeBavaC), an active compound from Psoraleae Fructus, in regulating white matter neuroinflammation to improve vascular cognitive impairment. Male Sprague-Dawley(SD) rats were randomly divided into four groups: sham group, model group, high-dose MeBavaC group(14 mg·kg~(-1)), and low-dose MeBavaC group(7 mg·kg~(-1)). The rat model of chronic cerebral hypoperfusion(CCH) was established using bilateral common carotid artery occlusion. The Morris water maze test was performed to evaluate the learning and memory abilities of the rats. Luxol fast blue staining, Nissl staining, immunofluorescence, immunohistochemistry, and transmission electron microscopy were utilized to observe the morphology and ultrastructure of the white matter myelin sheaths, axon integrity, the morphology and number of hippocampal neurons, and the loss and activation of glial cells in the white matter. Transcriptome analysis was performed to explore the potential mechanisms of white matter injury induced by CCH. Western blot and quantitative real-time polymerase chain reaction(qRT-PCR) assays were conducted to measure the expression levels of NOD-like receptor protein 3(NLRP3), absent in melanoma 2(AIM2), gasdermin D(GSDMD), cysteinyl aspartate-specific proteinase-1(caspase-1), interleukin-18(IL-18), interleukin-1β(IL-1β), erythropoietin(EPO), nuclear factor erythroid 2-related factor 2(Nrf2), and heme oxygenase-1(HO-1) in the white matter of rats. The results showed that compared with the model group, MeBavaC significantly improved the learning and memory abilities of rats with CCH, improved the damage of white matter myelin sheath, maintained axonal integrity, reduced the loss of hippocampal neurons and oligodendrocytes in the white matter, inhibited the activation of microglia and the proliferation of astrocytes in the white matter, and suppressed the NLRP3/AIM2/caspase-1/GSDMD pathway. The expression levels of inflammatory cytokines IL-1β and IL-18 were significantly reduced, while EPO expression and the expression of Nrf2/HO-1 antioxidant pathway were notably elevated. In conclusion, MeBavaC can alleviate cognitive impairment in rats with CCH and suppress neuroinflammation in cerebral white matter. The mechanism of action may involve activation of EPO activity, promotion of endogenous antioxidant pathways, and inhibition of neuroinflammation in the white matter. This study suggests that MeBavaC exhibits antioxidant and anti-neuroinflammatory effects, showing potential application in improving cognitive dysfunction.
